Kenilworth's role will likely be slight, in this purported MDL, as it acts merely as a fluoroquinolone distributor, not a
manufacturer, if I understand the fact pattern correctly, here. I think (if memory serves) Merck distributes for Bayer, under an old contract -- and Avelox
® is one of a wide class of fluoroquinolones on market, in the US. My backgrounder here --
when this was transferred, from Chicago to Minneapolis -- last September.
In any event, here is the new status hearing date -- which promises to be a very chilly trip north in January, for anyone headed to the federal District Court in Minneapolis:
. . . .Initial Status Conference is now set for 1/12/2016 at 01:30 PM in Courtroom 15E (MPLS) before Chief Judge John R. Tunheim. . . .
Onward, and smoothly, so. . .
2 comments:
on a different note, what do you think:
http://www.slate.com/blogs/quora/2015/12/01/hillary_clinton_how_can_we_make_prescriptions_more_affordable.html
All I can say is that I hope she is elected. The best of a lot of poor choices...
Namaste
Post a Comment